Evidence map›Paper›PMID 31175217›Full record

ReviewThe Journal of pharmacology and experimental therapeutics2019

Microneedle Coating Methods: A Review with a Perspective.

Rohan S J Ingrole, Harvinder Singh Gill

Abstract readReview
In one paragraph

Review in The Journal of pharmacology and experimental therapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Smart micro/nanoneedles for gene delivery.Iranian journal of basic medical sciences · 2026
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Construction and applications of exosome-microneedle integrated systems.International journal of pharmaceutics: X · 2025
    Review
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rohan S J IngroleDepartment of Chemical Engineering, Texas Tech University, Lubbock, Texas.
Harvinder Singh GillDepartment of Chemical Engineering, Texas Tech University, Lubbock, Texas harvinder.gill@ttu.edu.

Funding

Microneedles for treatment of peanut allergyR01AI135197 · NIAID · TEXAS TECH UNIVERSITY · PI GILL, HARVINDER SINGH · 2018 to 2022
$3.3M
Microneedles for allergy immunotherapyR01AI121322 · NIAID · TEXAS TECH UNIVERSITY · PI GILL, HARVINDER SINGH · 2016 to 2020
$1.8M
NIAID NIH HHS R01 AI121322NIAID NIH HHS R01 AI135197
6 · The paper itself

Abstract

A coated microneedle array comprises sharp micrometer-sized needle shafts attached to a base substrate and coated with a drug on their surfaces. Coated microneedles are under investigation for drug delivery into the skin and other tissues, and a broad assortment of active materials, including small molecules, peptides, proteins, deoxyribonucleic acids, and viruses, have been coated onto microneedles. To coat the microneedles, different methods have been developed. Some coating methods achieve selective coating of just the microneedle shafts, whereas other methods coat not only microneedle shafts but also the array base substrate. Selective coating of just the microneedle shafts is more desirable since it provides control over drug dosage, prevents drug waste, and offers high delivery efficiency. Different excipients are added to the coating liquid to modulate its viscosity and surface tension in order to achieve uniform coatings on microneedles. Coated microneedles have been used in a broad range of biomedical applications. To highlight these different applications, a table summarizing the different active materials and the amounts coated on microneedles is provided. We also discuss factors that should be considered when deciding suitability of coated microneedles for new-drug delivery applications. In recent years, many coated microneedles have been investigated in human clinical trials, and there is now a strong effort to bring the first coated microneedle-based product to market.

Indexed as

NeedlesAdministration, CutaneousAnimalsDrug Delivery SystemsHumansMicroinjectionsTechnology, Pharmaceutical

Identifiers

PMID31175217
PMCPMC6806358

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.